Gain Therapeutics, Inc.

Gain Therapeutics, Inc. Common Stock (GANX) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.

GANX has 2 Form 4 insider filings recorded at the SEC in the past 30 days[1].

Sources:
[1] SEC EDGAR, 0001819411. Source last updated 2026-04-11, retrieved 2026-04-11.
    https://efts.sec.gov/LATEST/search-index?q=%22GANX%22&forms=4&dateRange=custom&startdt=2026-03-12&enddt=2026-04-11

<article class="bts-verified-summary" data-ticker="GANX">
<p>Gain Therapeutics, Inc. Common Stock (GANX) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.</p>
<p>GANX has 2 Form 4 insider filings recorded at the SEC in the past 30 days<sup><a href="#fn-1">[1]</a></sup>.</p>
<section class="sources" data-nosnippet aria-label="Sources"><h3>Sources</h3><ol><li id="fn-1">SEC EDGAR · 0001819411 (2026-04-11) <a href="https://efts.sec.gov/LATEST/search-index?q=%22GANX%22&amp;forms=4&amp;dateRange=custom&amp;startdt=2026-03-12&amp;enddt=2026-04-11" rel="nofollow noopener noreferrer">↗</a></li></ol></section>
</article>